46.46.Z - Wholesale trade of pharmaceutical and medical products
41.10.Z - Construction work related to the construction of residential and non-residential buildings
41.20.Z - Construction work related to the construction of residential and non-residential buildings
47.73.Z - Retail sale of pharmaceutical products
66.30.Z - Activities related to fund management
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
68.31.Z - Real estate brokerage
68.32.Z - Other real estate activities on behalf of third parties
82.92.Z - Packaging activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,3 | 1,2 | 3 | 142,4 |
EBITDA | 0,3 | 1,3 | 3 | 127,8 |
Short time liabilities | 1,5 | 2,1 | 2,4 | 14,4 |
Equity capital | 0,8 | 2,3 | 5,3 | 131 |
Operating profit (EBIT) | 0,3 | 1,3 | 3 | 127,8 |
Assets | 2,3 | 4,4 | 7,8 | 74,7 |
Net profit (loss) | 0,3 | 1,2 | 3 | 142,2 |
Cash | 0 | 1 | 1,5 | 54,2 |
Liabilities and provisions for liabilities | 1,5 | 2,1 | 2,4 | 14,4 |
Net income from sale | 8,8 | 18,1 | 26,2 | 44,3 |
Working assets | 2,3 | 4,4 | 7,8 | 74,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 33,8 | 54,1 | 56,7 | 2,6 |
Equity capital to total assets | 35,2 | 51,8 | 68,4 | 16,6 |
Gross profit margin | 3,4 | 6,9 | 11,5 | 4,6 |
EBITDA Margin | 3,7 | 7,3 | 11,5 | 4,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 61 | 43 | 34 | -9 |
Current financial liquidity indicator | 1.542665719985962 | 2.0727672576904297 | 3.1652514934539795 | 1,1 |
Net dept to EBITDA | 0.1280873715877533 | -0.739787757396698 | -0.5009381175041199 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane